Ian Shakil, CHIEF STRATEGY OFFICER at Augmedix, Inc. (AUGX), sold 169,117 shares at $3.97 ($678K) on 2024-04-08, disclosed to the SEC on 2024-04-09.
Scheduled sale ($678k) by CHIEF STRATEGY OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.03 | 51,387 | $207K | 30.6% |
| 2 | $4.03 | 51,387 | $207K | 30.6% |
| 3 | $3.97 | 9,217 | $37K | 5.4% |
| 4 | $3.97 | 28,563 | $113K | 16.7% |
| 5 | $3.97 | 28,563 | $113K | 16.7% |
| Total | $4.01 avg | 169,117 |
| $678K |
| 100% |
| Filing → |
| AUGX | SELL | 2024-04-15 | $149K | — | Filing → |
| AUGX | SELL | 2024-04-11 | $738K | — | Filing → |
| AUGX | SELL | 2024-04-09 | $260K | — | Filing → |